1-7 of 7
Marijke van den Berg, MD, PhD
Close
Sort by
Journal Articles

99.3% of Inhibitors in Severe Hemophilia a Develop before Exposure Day 75. Time to Change Definition of Previously Treated Patients; Data from 1038 Patients with Severe Hemophilia a of the Pednet Registry

Marijke Van den Berg, MD PhD, Kathelijn Fischer, Elena Santagostino, Herve Chambost, Karin Kurnik, Gili Kenet, MD, Christoph Male, MD, Anne Rafowicz, Helen Platokouki, Susanna Ranta, MD PhD, Christel Van Geet, MD, Johannes Oldenburg, Ri Liesner, Segolene Claeyssens, MD, Nadine Gretenkort-Andersson, Anne Mäkipernaa, PhD, Torben Stamm Mikkelsen, Manuel Carcao, Beatrice Nolan, Liz Chalmers, A.R. Cid, Teresa Álvarez-Roman, Carmen Altisent, Georges Rivard, MD FRCPC, Claudio Molinari, Martina Buehrlen, Rainer Kobelt, Carmen Escuriola, Manuela Carvalho, Christoph Koenigs, MD PhD, Mike Williams, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2018) 132 (Supplement 1): 2472.
https://doi.org/10.1182/blood-2018-99-114518
Published: 2018
Journal Articles

Risk Factors for the Development of High-Titer Inhibitors in 260 Children with Severe Hemophilia a Born Between 1990 and 2009: The Remain Study

Maria Elisa Mancuso, MD PhD, Kathelijn Fischer, MD PhD MSc, Elena Santagostino, MD PhD, Johannes Oldenburg, Prof, Helen Platokouki, MD, Christoph Königs, MD PhD, Carmen Escuriola, MD, Georges-Etienne Rivard, MD, Ana Cid, MD, Manuel Carcao, MD, Rolf Ljung, MD PhD, Pia Petrini, MD, Anne Rafowicz, MD, Carmen Altisent, MD, Gili Kenet, MD, Raina Liesner, Karin Kurnik, MD, Christel Van Geet, MD PhD, Teresa Alvarez-Roman, MD, Tin Tin Yee, MD, Guenter Auerswald, Sr., MD, Rosario Perez-Garrido, MD, Beatrice Nolan, Hervé Chambost, Anne Makipernaa, MD, Angelo Claudio Molinari, MD, Angela Thomas, MBBS, PhD, Elizabeth Chalmers, MD, Mike Williams, MD, Rainer Kobelt, MD, Marijke Van den Berg, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3774.
https://doi.org/10.1182/blood.V128.22.3774.3774
Published: 2016
Journal Articles

O -Linked Glycosylation with Sialylated T-Antigen: A Novel Carbohydrate Determinant of von Willebrand Factor Antigen Levels.

Peter J. Lenting, PhD, Carina J.M. van Schooten, MSc, Ton Lisman, PhD, Marijke van den Berg, MD, PhD, Jeroen C.J. Eikenboom, MD, PhD, Frank W.G. Leebeek, MD, PhD, Jenny Goudemand, MD, PhD, Edith Fressinaud, MD, PhD, Philip G. de Groot, PhD, Cécile V. Denis, PhD
Journal: Blood
Blood (2006) 108 (11): 178.
https://doi.org/10.1182/blood.V108.11.178.178
Published: 2006
Journal Articles

Outcome Assessment in Hemophilia: A Pilot Study on Correlation of Different Instruments.

Kathelijn Fischer, MD, PhD, Frank R. Van Genderen, MSc, PhD, Piet De Kleijn, Marijke Van den Berg, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 1032.
https://doi.org/10.1182/blood.V108.11.1032.1032
Published: 2006
Journal Articles

Factor VIII Half-Life and Clinical Characteristics of Severe Hemophilia A.

Karin van Dijk, MD, Johanna G. van der Bom, MD, PhD, Eveline P. Mauser-Bunschoten, MD, PhD, Goris Roosendaal, MD, PhD, Peter J. Lenting, PhD, Philip G. de Groot, PhD, H. Marijke van den Berg, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3091.
https://doi.org/10.1182/blood.V104.11.3091.3091
Published: 2004
Journal Articles

Variability in Bleeding Pattern of Severe Hemophilia.

Karin van Dijk, MD, Kathelijn Fischer, MD, PhD, Johanna G. van der Bom, MD, PhD, Eveline P. Mauser-Bunschoten, MD, PhD, Goris Roosendaal, MD, PhD, H. Marijke van den Berg, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3094.
https://doi.org/10.1182/blood.V104.11.3094.3094
Published: 2004
Journal Articles

Incidence and Outcome of Discontinuation of Prophylactic Treatment among Young Adults with Severe Hemophilia.

Karin van Dijk, MD, Kathelijn Fischer, MD, PhD, Johanna G. van der Bom, MD, PhD, Elma Scheibel, MD, PhD, Jørgen Ingerslev, MD, PhD, H. Marijke van den Berg, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3086.
https://doi.org/10.1182/blood.V104.11.3086.3086
Published: 2004